協和キリンJP:4151バランスシート

時価総額
¥1.35兆
PER
23.6倍
医療用医薬品の製造および販売を手がける企業で、主要な事業として医薬品の開発と提供を行う。
2013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物-20,65713,23613,0667,2347,92520,762287,019335,084339,194403,083244,681
有価証券-----7363896361,4345261,9231,705
売掛金-108,867106,829100,999-104,44389,01592,287104,275111,746119,082157,015
商品及び製品-67,72461,96551,34918,92819,70647,12351,28164,08970,67571,36372,933
流動資産合計-283,192324,433326,469299,134335,369448,610442,482518,231542,189611,124504,026
有形固定資産-151,891147,043151,04755,70552,80274,21676,01278,65289,09994,508111,477
投資有価証券-22,76614,04311,4127,7578,69519,51117,32345,16436,53133,37432,800
固定資産合計-435,943396,331370,698232,767234,531335,843358,808403,641397,692414,818563,337
総資産-719,135720,764697,167531,901741,982784,453801,290921,872939,8811,025,9421,067,363
買掛金-22,72919,08618,230-49,40053,87754,86764,65270,92292,983121,063
短期借入金-4,8684,8405,360-2,2093,1095,1235,9435,7298,1364,628
流動負債合計-85,18284,82379,41652,73261,44487,53080,749109,129109,825133,237164,675
長期借入金------------
固定負債合計-28,58421,08217,0062,5616,04318,67322,14575,58167,22956,28751,876
総負債-113,766105,90696,42255,29392,362106,204102,894184,710177,055189,524216,551
資本金及び資本剰余金-539,071535,872130,555130,572666,494621,190621,356621,721622,195622,641585,030
利益剰余金-68,10385,99790,986368,275393,238201,253226,639255,528285,842338,764371,050
株主資本595,415605,368614,858600,745476,609502,413678,250698,396737,162762,826836,418850,811